Anebulo Pharmaceuticals, Inc. (ANEB) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 2.62M | 2.26M | 2.33M | 1.89M | 2.59M | 2.41M | 1.34M | 1.66M | 2.76M | 2.54M | 2.49M | 2.86M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.46M | 1.45M | 1.2M | 1.25M | 1.37M | 1.1M | 872.66K | 915.91K | 1.7M | 1.27M | 1.08M | 1.77M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 1.16M | 809.99K | 1.13M | 638.32K | 1.22M | 1.31M | 467.71K | 748.34K | 1.06M | 1.27M | 1.42M | 1.09M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -594 | 7.66K | 0 | 0 |
| Operating Income | -2.62M | -2.26M | -2.33M | -1.89M | -2.59M | -2.41M | -1.34M | -1.66M | -2.76M | -2.54M | -2.49M | -2.86M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -1.23% | 6.29% | -73.9% | -13.7% | 6.25% | 5.19% | 46.26% | 41.89% | 27.61% | 2.61% | -7.26% | -52.37% |
| EBITDA | -2.62M | -2.14M | -2.13M | -1.43M | -2.59M | -2.14M | -1.29M | -1.59M | -2.76M | 0 | -2.5M | -2.8M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -1.23% | -0% | -64.88% | 10.22% | 6.15% | - | 48.3% | 43.03% | 27.94% | 100% | -7.1% | -49.1% |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 3 | 271.09K | 0 | 0 | 2.76K | 2.54M | 0 | 66.07K |
| EBIT | -2.62M | -2.14M | -2.13M | -1.43M | -2.4M | -2.14M | -1.29M | -1.59M | -2.69M | -2.48M | -2.5M | -2.8M |
| Net Interest Income | 67.97K | 92.18K | 105.14K | -142.93K | -52.63K | -33.69K | -9.48K | 8.39K | 43.68K | 55.2K | 0 | 79.15K |
| Interest Income | 85.41K | 109.62K | 122.58K | 102.26K | 7.07K | 26.01K | 50.22K | 68.08K | 75.52K | 55.2K | 0 | 79.15K |
| Interest Expense | 17.44K | 17.44K | 17.44K | 245.18K | 59.7K | 59.7K | 59.7K | 59.7K | 31.84K | 0 | 0 | 0 |
| Other Income/Expense | 620.51K | 101.91K | 186.06K | 216.15K | 125.12K | 211.39K | -9.6K | 10.71K | 43.09K | 62.85K | -1.19K | 66.07K |
| Pretax Income | -2M | -2.16M | -2.14M | -1.68M | -2.46M | -2.2M | -1.35M | -1.65M | -2.72M | -2.48M | -2.5M | -2.8M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -2M | -2.16M | -2.14M | -1.68M | -2.46M | -2.2M | -1.35M | -1.65M | -2.72M | -2.48M | -2.5M | -2.8M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 18.82% | 1.94% | -58.88% | -1.37% | 9.36% | 11.29% | 45.91% | 40.9% | 28.99% | 5.01% | -7.44% | -49.11% |
| Net Income (Continuing) | -2M | -2.16M | -2.14M | -1.68M | -2.46M | -2.2M | -1.35M | -1.65M | -2.72M | -2.48M | -2.5M | -2.8M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.05 | -0.05 | -0.05 | -0.06 | -0.09 | -0.08 | -0.05 | -0.06 | -0.11 | -0.10 | -0.10 | -0.11 |
| EPS Growth % | 45.77% | 38.16% | 0.19% | 4.23% | 18.36% | 12.29% | 47.7% | 42% | 26.67% | 12% | 0% | -37.16% |
| EPS (Basic) | -0.05 | -0.05 | -0.05 | -0.04 | -0.09 | -0.08 | -0.05 | -0.06 | -0.11 | -0.10 | -0.10 | -0.11 |
| Diluted Shares Outstanding | 41.08M | 41.08M | 41.08M | 27.41M | 27.41M | 25.93M | 25.82M | 25.93M | 25.79M | 25.63M | 25.07M | 25.63M |
| Basic Shares Outstanding | 41.08M | 41.08M | 41.09M | 27.41M | 27.41M | 25.93M | 25.82M | 25.93M | 25.79M | 25.63M | 25.07M | 25.63M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |